VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NKGNNKGen Biotech, Inc. Common Stock
$0.06$3M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNKGNPrice History

NKGN logoNKGen Biotech, Inc. Common Stock (NKGN) Stock Price History

Historical prices from 2023 to 2026

$0.06+0.00  (+0.00%)close Jun 18
Returns
1M
+0.0%
3M
-62.5%
YTD
+20.0%
1Y
-75.0%
3Y
-78.1%
5Y
-59.8%
ATH$6.70Oct 2023-99.1%
ATL$0.00Oct 2025pre-split
Avg Vol (50D)4K/ day
52-Week Range$0.00 — $0.38
LowCurrent: $0.06High

Loading 10-year price history...

NKGN Historical Performance

1 YearTotal Return
-75.0%
Price: -75.0%
3 YearsTotal Return
-98.9%
CAGR: -78.1%
Price: -98.9%
5 YearsTotal Return
-98.9%
CAGR: -59.8%
Price: -98.9%
YTD
+20.0%

NKGN Annual Returns

Year-by-year price performance · 2023–2026

Best-51.8%2023
Worst-92.8%2025
Up years1/4
2023-51.8%
2024-78.4%
2025-92.8%
2026+20.0%
2023 annual price return
-51.8%
2024 annual price return
-78.4%
2025 annual price return
-92.8%
2026 annual price return
+20.0%
LessMore
Alpha vs S&P 500
1Y-100.0%
3Y-97.6%
5Y-72.3%

Price returns only.

Download Historical Data

656 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NKGN Stock Price Trajectory (2023–2026)

As of June 22, 2026, NKGen Biotech, Inc. Common Stock (NKGN) trades at $0.06, representing a -75.0% return over the past year. The stock has delivered a -98.9% total return over five years (-59.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $6.70 on October 2, 2023. From this peak, NKGN has corrected -99.1%, currently trading 18% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers FATE (+72.7% 1Y), NKTX (+57.1% 1Y), and CELC (+643.1% 1Y), NKGN has underperformed the peer group average. Compare NKGN vs FATE →

NKGN Historical Price Data · from 2023

Rows 1–50 of 656
Date Open High Low Close Volume Change %
2026-06-180.060.060.060.063700.00%
2026-06-170.060.060.060.062K0.00%
2026-06-160.060.060.060.062K-60.00%
2026-06-150.060.150.060.15922+150.00%
2026-06-120.060.060.060.0621K0.00%
2026-06-110.060.060.060.061K0.00%
2026-06-100.060.060.060.065040.00%
2026-06-090.060.060.060.062K0.00%
2026-06-030.060.060.060.064950.00%
2026-06-020.060.060.060.065000.00%
2026-06-010.060.060.060.0627K0.00%
2026-05-290.060.060.060.061K0.00%
2026-05-280.060.060.060.062010.00%
2026-05-270.060.060.060.062100.00%
2026-05-220.060.060.060.0651K0.00%
2026-05-210.060.060.060.061K0.00%
2026-05-200.060.060.060.061500.00%
2026-05-180.060.060.060.061640.00%
2026-05-140.060.060.060.0600.00%
2026-05-130.060.060.060.0600.00%
2026-05-120.060.060.060.06105-20.00%
2026-05-110.080.080.070.076K-53.13%
2026-05-080.160.160.160.162K+166.67%
2026-05-060.060.060.060.061840.00%
2026-05-010.060.060.060.061000.00%
2026-04-290.060.060.060.061200.00%
2026-04-270.060.060.060.0600.00%
2026-04-240.060.060.060.063010.00%
2026-04-230.060.060.060.061750.00%
2026-04-220.060.060.060.0621K0.00%
2026-04-200.060.060.060.062000.00%
2026-04-170.060.060.060.06349-14.29%
2026-04-160.070.070.070.07135+16.67%
2026-04-150.060.060.060.06134-62.50%
2026-04-130.100.160.100.162K+166.67%
2026-04-090.060.060.060.061910.00%
2026-04-080.060.060.060.061180.00%
2026-04-060.060.060.060.065100.00%
2026-04-020.060.060.060.065100.00%
2026-04-010.060.060.060.06102-14.29%
2026-03-300.060.070.060.071K+16.67%
2026-03-260.060.060.060.063K0.00%
2026-03-250.060.060.060.063K-62.50%
2026-03-230.160.160.160.162K+6.67%
2026-03-190.150.150.150.152K-6.25%
2026-03-180.160.160.160.162K+166.67%
2026-03-170.060.060.060.065K0.00%
2026-03-160.060.060.060.062110.00%
2026-03-130.060.100.060.067K-66.67%
2026-03-110.180.180.180.181K0.00%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NKGN — Frequently Asked Questions

Quick answers to the most common questions about buying NKGN stock.

How has NKGN stock performed recently?

NKGN declined -75.0% over the past year, below its 5-year annualized CAGR of -59.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is NKGN's all-time high price?

NKGen Biotech, Inc. Common Stock reached $6.70 on 2023-10-02. The 52-week high is $0.38. Current 1-year return of -75.0% places the stock further from historical peaks.

Where can I download NKGN historical price data?

This page provides NKGN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2023-2026, downloadable in CSV format.

329 data points · sampled from 656